These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24443913)

  • 1. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
    Jung GW; Dover DC; Salopek TG
    Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
    Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
    Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between multiple cutaneous melanoma and other primary neoplasms.
    Manganoni AM; Pavoni L; Farisoglio C; Sereni E; Chiudinelli M; Calzavara-Pinton P
    Clin Exp Dermatol; 2012 Dec; 37(8):857-61. PubMed ID: 23020153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
    Troyanova P; Danon S; Ivanova T
    Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
    Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
    Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
    Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
    J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.
    Silverberg JI; Ratner D
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1389-97. PubMed ID: 25491569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study.
    Ong EL; Goldacre R; Hoang U; Sinclair R; Goldacre M
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):490-8. PubMed ID: 24609853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of invasive cancers following cutaneous malignant melanoma.
    Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
    Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
    J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan.
    Hwang CY; Chen YJ; Lin MW; Chen TJ; Chu SY; Chen CC; Lee DD; Chang YT; Wan WJ; Liu HN
    J Dermatol Sci; 2010 Dec; 60(3):167-72. PubMed ID: 21036546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
    Schenk M; Severson RK; Pawlish KS
    Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological comparisons of index and second primary melanomas in paediatric and adult populations.
    Jung GW; Weinstock MA
    Br J Dermatol; 2012 Oct; 167(4):882-7. PubMed ID: 22716099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.